Basal cell carcinoma - Basalis Cellula Carcinoma
☆ AI Dermatology — Free Service
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Laesiones exulceratae quae cutem nasi in senibus afficiunt saepe dignoscuntur ut Carcinoma basocellulare (Basal cell carcinoma). Nasus est locus communis huius generis canceris cutis.
Carcinoma basocellulare (Basal cell carcinoma) verruca falli potest.
relevance score : -100.0%
ReferencesBasal cell carcinoma (BCC) est frequentissimum genus cancri cutis. Solis est causa principalis. Fere omnes casus BCC signum overactivum viae Hedgehog ostendunt. Variae curationes praesto sunt et electae secundum periculum recidivae, momentum conservationis textus, praeferentiam patientis, et amplitudinem morbi.
Basal cell carcinoma (BCC) is the most common malignancy. Exposure to sunlight is the most important risk factor. Most, if not all, cases of BCC demonstrate overactive Hedgehog signaling. A variety of treatment modalities exist and are selected based on recurrence risk, importance of tissue preservation, patient preference, and extent of disease.
Basal cell carcinoma (BCC) is the most common malignancy. Exposure to sunlight is the most important risk factor. Most, if not all, cases of BCC demonstrate overactive Hedgehog signaling. A variety of treatment modalities exist and are selected based on recurrence risk, importance of tissue preservation, patient preference, and extent of disease.
Basal cell carcinomas (Basal cell carcinomas) frequentissimae sunt cancri cutis in adultis pulchri cutis super 50 annos. Eorum numerus in orbem terrarum oriuntur, maxime ob expositionem solis. Quaedam condiciones geneticae facile possunt efficere ut haec carcinomata in minore aetate occurrant. Basal cell carcinomas in severitate variantur, ex facili tractabili laesiones superficiales vel nodulares ad ampliora quae discussionem requirunt in specialibus iunctionibus medicis. Prognosis pendet a probabilitate cancri redeundi vel eius facultate laedendi prope textum. Chirurgia (Surgery) est norma curatio in pluribus casibus, praecise remotionis et casus humilitatis recurrentis. Modi incursivi minus efficaciter laesiones superficiales tractare possunt.
Basal cell carcinomas are the most frequent skin cancers in the fair-skinned adult population over 50 years of age. Their incidence is increasing throughout the world. Ultraviolet (UV) exposure is the major carcinogenic factor. Some genodermatosis can predispose to formation of basal cell carcinomas at an earlier age. Basal cell carcinomas are heterogeneous, from superficial or nodular lesions of good prognosis to very extensive difficult-to-treat lesions that must be discussed in multidisciplinary committees. The prognosis is linked to the risk of recurrence of basal cell carcinoma or its local destructive capacity. The standard treatment for most basal cell carcinomas is surgery, as it allows excision margin control and shows a low risk of recurrence. Superficial lesions can be treated by non-surgical methods with significant efficacy.
Basal cell carcinomas are the most frequent skin cancers in the fair-skinned adult population over 50 years of age. Their incidence is increasing throughout the world. Ultraviolet (UV) exposure is the major carcinogenic factor. Some genodermatosis can predispose to formation of basal cell carcinomas at an earlier age. Basal cell carcinomas are heterogeneous, from superficial or nodular lesions of good prognosis to very extensive difficult-to-treat lesions that must be discussed in multidisciplinary committees. The prognosis is linked to the risk of recurrence of basal cell carcinoma or its local destructive capacity. The standard treatment for most basal cell carcinomas is surgery, as it allows excision margin control and shows a low risk of recurrence. Superficial lesions can be treated by non-surgical methods with significant efficacy.
Curatio prima BCC chirurgica est. Pro magno periculo vel BCC recurrenti, praesertim in locis criticis, chirurgia micrographice controlata commendatur. Aegris cum humili periculo superficiali BCC tractationes topicas vel methodos destructivos considerare possunt. Photodynamica therapia bene operatur pro BCC nodularibus superficialis et humilis. Pro BCC localiter provecto vel metastatico, inhibitores Hedgehog (vismodegib, sonidegib) commendantur. Si progressio morbi vel intolerantia ad inhibitores Hedgehog est, immunotherapia cum anti‑PD1 antibody (cemiplimab) considerari potest. Radiotherapia optima optio est aegrotis qui chirurgiam habere non possunt, praesertim senioribus. Electrochemotherapia considerari potest si chirurgia vel radiotherapia optio non est.
The primary treatment for BCC is surgery. For high-risk or recurring BCC, especially in critical areas, micrographically controlled surgery is recommended. Patients with low-risk superficial BCC might consider topical treatments or destructive methods. Photodynamic therapy works well for superficial and low-risk nodular BCCs. For locally advanced or metastatic BCC, Hedgehog inhibitors (vismodegib, sonidegib) are recommended. If there's disease progression or intolerance to Hedgehog inhibitors, immunotherapy with anti-PD1 antibody (cemiplimab) can be considered. Radiotherapy is a good option for patients who can't have surgery, especially older patients. Electrochemotherapy could be considered if surgery or radiotherapy isn't an option.
The primary treatment for BCC is surgery. For high-risk or recurring BCC, especially in critical areas, micrographically controlled surgery is recommended. Patients with low-risk superficial BCC might consider topical treatments or destructive methods. Photodynamic therapy works well for superficial and low-risk nodular BCCs. For locally advanced or metastatic BCC, Hedgehog inhibitors (vismodegib, sonidegib) are recommended. If there's disease progression or intolerance to Hedgehog inhibitors, immunotherapy with anti-PD1 antibody (cemiplimab) can be considered. Radiotherapy is a good option for patients who can't have surgery, especially older patients. Electrochemotherapy could be considered if surgery or radiotherapy isn't an option.
Factorum periculorum includunt expositionem ad lucem ultravioletam, radiationem, diuturnam expositionem ad arsenicum, et immunitatis defectum (e.g., transplantationem organorum). Expositio ad lucem UV in pueritia maxime nocet.
Post diagnosticationem per biopsy, curatio typice est remocio chirurgica. Id potest esse excisio simplex, si cancer parvus est; si cancer maior est, chirurgia Mohs plerumque commendatur.
Carcinoma basocellulare saltem 32% omnium carcinomatum globaliter computatur. Carcinomata cutis praeter melanoma circiter 80% sunt carcinomata basocellulare. In Civitatibus Foederatis, circiter 35% virorum alborum et 25% feminarum alborum afficiuntur carcinoma basocellulare aliquando in vita sua.
○ Diagnosis et curatio
#Dermoscopy
#Skin biopsy
#Mohs surgery